evenfolioETF Details
Amplify ETFs·Health·THNR · NYSE Arca
Amplify Weight Loss Drug & Treatment ETF (THNR)
- Price
- $25.69
- —25 Sept 2026
- Assets
- $5.3M
- Total net assets
- Expense ratio
- 0.59%
- Category 1.00%
- Yield
- 1.55%
- Trailing distributions
- 1Y return
- 14.9%-21.2%
- Category 36.0%
- 3Y CAGR
- —
- Category 16.5%
- 5Y CAGR
- —
- Category 2.9%
Loading NAV history…
Amplify Weight Loss Drug & Treatment ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -7.4% | +1.3% | +8.6% | +1.9% | +14.9% | — | — | — | +1.6% |
| Health average | -3.2% | 5.9% | 25.6% | 16.1% | 36.0% | 16.5% | 2.9% | 9.1% | 11.4% |
| Difference | -4.1% | -4.6% | -17.0% | -14.3% | -21.2% | — | — | — | -9.9% |
Holdings
The 10 largest positions make up 62.5% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| NVO | Novo Nordisk AS ADR | 8.89% |
| LLY | Eli Lilly and Co | 8.61% |
| 1801.HK | Innovent Biologics Inc | 6.33% |
| REGN | Regeneron Pharmaceuticals Inc | 6.02% |
| 1093.HK | CSPC Pharmaceutical Group Ltd | 5.75% |
| SRRK | Scholar Rock Holding Corp | 5.69% |
| AMGN | Amgen Inc | 5.59% |
| MRK | Merck & Co Inc | 5.48% |
| ABBV | AbbVie Inc | 5.11% |
| PFE | Pfizer Inc | 5.00% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 21.7
- P/B
- 4.9
- P/S
- 5.1
- P/CF
- 17.7
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.3%
- Cash0.5%
- Other0.2%
ETF details
- Issuer
- Amplify ETFs
- Category
- Equity · Health
- Ticker
- THNR
- Exchange
- NYSE Arca
- Inception
- 20 May 2024 (2.3 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.59% (category 1.00%)
- Holdings turnover
- 70% (category 51%)
- Distribution yield
- 1.55%
- Beta, 3 years
- 0.00
- Total net assets
- $5.3M
Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- EKG · First Trust Nasdaq Lux Digital Health Solutions ETFFirst Trust · $4.4M · ER 0.65%
- NVOH · Novo Nordisk A/S (B Shares) ADRhedgedADRH · $3.9M · ER 0.19%
- WDNA · WisdomTree BioRevolution FundWisdomTree · $3.5M · ER 0.45%5Y -0.9%
- MDEV · First Trust Indxx Medical Devices ETFFirst Trust · $3.2M · ER 0.70%5Y -5.4%
- GNMX · Corgi Genomics & Precision Medicine ETFCorgi Funds · $1.9M · ER 0.35%
- ASD · Defiance Autism Impact ETFDefiance ETFs LLC · $1.4M · ER 0.79%